List view / Grid view

Novo Nordisk

 

article

Leveraging PAT for environmental monitoring in light of Annex 1

8 September 2023 | By

The pharma industry’s adaptation to Industry 4.0 has been slow, due to the extensive regulatory requirements imposed on manufacturers. However, regulatory agencies are starting to embrace movement towards more rapid/automated systems, as illustrated in the revised EU GMP Annex 1, which entered into force in August. Here, Isabella Jul-Jørgensen from the Technical…